Conventional brain MRI features distinguishing limbic encephalitis from mesial temporal glioma
- 110 Downloads
Radiological hallmark of autoimmune limbic encephalitis (LE) is a hyperintense signal in MRI T2-weighted images of mesial temporal structures. We aimed to identify conventional magnetic resonance imaging (MRI) features that can help distinguish LE from temporal glioma.
Brain MRIs of 25 patients affected by antibody-positive autoimmune LE, 24 patients affected by temporal glioma (tumor group), and 5 negative controls were retrospectively blindly evaluated in random order.
Ten brain MRIs from the LE group were correctly recognized; one additional patient with mesial temporal hyperintensity with anti-AK5 abs LE was wrongly diagnosed as having a tumor. The brain MRIs of the remaining 14 of the 25 patients with LE were judged negative or, in three cases, showed features not typical for LE. In the tumor group, all MRIs showed pathological alterations diagnosed as tumors in 22/24 cases and as LE in two (2/22, 9%). Unilateral lesions were more common in tumors than in neuroradiologically abnormal LE (96% vs. 18%, p < 0.001). T2/FLAIR hyperintensity of the parahippocampal gyrus was associated more with tumor than with LE (71% vs. 18%) (p = 0,009), as T2/FLAIR hyperintensity of extralimbic structures (p = 0.015), edema (p = 0.041), and mass effect (p = 0.015). Maintenance of gray/white matter distinction was strongly associated with LE (91% vs. 17%, p < 0.001).
Conventional brain MRI is a fundamental tool in the differential diagnosis between LE and glioma. Bilateral involvement and maintenance of gray/white matter distinction at the cortical/subcortical interface are highly suggestive of LE.
KeywordsLimbic encephalitis Glioma Neuronal antibodies Brain MRI AK5 antibodies
The authors thank Francesc Graus (Barcelona, Spain) for providing cell-based assay for AK5 antibody and Angela Vincent (Oxford, UK) for VGKC radioimmunoassay, and Joanne Fleming for reviewing the manuscript.
No funding was received for this study.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
All procedures performed in the studies involving human participants were in accordance with the ethical standards of our institutional research committees and with the 1964 Helsinki Declaration and its later amendments.
Informed consent was obtained from all individual participants included in the study.
- 2.Graus F, Titulaer MJ, Balu R, et al (2016) A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol 15:391–404. https://doi.org/10.1016/S1474-4422(15)00401-9
- 5.Saiz A, Blanco Y, Sabater L, González F, Bataller L, Casamitjana R, Ramió-Torrentà L, Graus F (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain 131:2553–2563. https://doi.org/10.1093/brain/awn183 CrossRefGoogle Scholar
- 6.Bernal F, Shams’ili S, Rojas I et al (2003) Anti-Tr antibodies as markers of paraneoplastic cerebellar degeneration and Hodgkin’s disease. Neurology. 60:230–234. https://doi.org/10.1212/01.WNL.0000041495.87539.98 CrossRefGoogle Scholar
- 7.van Sonderen A, Schreurs MWJ, de Bruijn MAAM, Boukhrissi S, Nagtzaam MMP, Hulsenboom ESP, Enting RH, Thijs RD, Wirtz PW, Sillevis Smitt PAE, Titulaer MJ (2016) The relevance of VGKC positivity in the absence of LGI1 and Caspr2 antibodies. Neurology 86:1692–1699. https://doi.org/10.1212/WNL.0000000000002637 CrossRefGoogle Scholar
- 8.Louis DN, Ohgaki H, Wiestler ODCW (2016) World Health Organization histological classification of tumours of the central nervous system. International Agency for Research on Cancer, FranceGoogle Scholar
- 11.Deramecourt V, Bombois S, Debette S, Delbeuck X, Ramirez C, Reyns N, Kerdraon O, Maurage CA, Pasquier F (2009) Bilateral temporal glioma presenting as a paraneoplastic limbic encephalitis with pure cognitive impairment. Neurologist. 15:208–211. https://doi.org/10.1097/NRL.0b013e31818fc022 CrossRefGoogle Scholar
- 14.Simo M, Dalmau J (2009) Cerebral gliomatosis simulating limbic encephalitis. Neurologia 24:500–501Google Scholar
- 17.Oyanguren B, Sánchez V, González FJ, de Felipe A, Esteban L, López-Sendón JL, Garcia-Barragán N, Martínez-San Millán J, Masjuán J, Corral I (2013) Limbic encephalitis: a clinical-radiological comparison between herpetic and autoimmune etiologies. Eur J Neurol 20:1566–1570. https://doi.org/10.1111/ene.12249 CrossRefGoogle Scholar
- 18.Kotsenas AL, Watson RE, Pittock SJ, Britton JW, Hoye SL, Quek AML, Shin C, Klein CJ (2014) MRI findings in autoimmune voltage-gated potassium channel complex encephalitis with seizures: one potential etiology for mesial temporal sclerosis. Am J Neuroradiol 35:84–89. https://doi.org/10.3174/ajnr.A3633 CrossRefGoogle Scholar
- 23.Do LD, Chanson E, Desestret V, Joubert B, Ducray F, Brugière S, Couté Y, Formaglio M, Rogemond V, Thomas-Antérion C, Borrega L, Laurens B, Tison F, Curot J, de Brouker T, Lebrun-Frenay C, Delattre JY, Antoine JC, Honnorat J (2017) Characteristics in limbic encephalitis with anti-adenylate kinase 5 autoantibodies. Neurology 88:514–524. https://doi.org/10.1212/WNL.0000000000003586 CrossRefGoogle Scholar
- 24.Flanagan EP, Kotsenas AL, Britton JW, McKeon A, Watson RE, Klein CJ, Boeve BF, Lowe V, Ahlskog JE, Shin C, Boes CJ, Crum BA, Laughlin RS, Pittock SJ (2015) Basal ganglia T1 hyperintensity in LGI1-autoantibody faciobrachial dystonic seizures. Neurology 2. https://doi.org/10.1212/NXI.0000000000000161
- 26.Urbach H, Rauer S, Mader I, Paus S, Wagner J, Malter MP, Prüss H, Lewerenz J, Kassubek J, Hegen H, Auer M, Deisenhammer F, Ufer F, Bien CG, Baumgartner A (2015) Supratentorial white matter blurring associated with voltage-gated potassium channel-complex limbic encephalitis. Neuroradiology 57:1203–1209. https://doi.org/10.1007/s00234-015-1581-x CrossRefGoogle Scholar
- 27.Kim JA, Chung J, Ho Yoon P et al (2001) Transient MR signal changes in patients with generalized tonicoclonic seizure or status epilepticus: Periictal diffusion-weighted imaging. Am J Neuroradiol 22:1149–1160Google Scholar
- 29.van Sonderen A, Thijs RD, Coenders EC, Jiskoot LC, Sanchez E, de Bruijn MAAM, van Coevorden-Hameete MH, Wirtz PW, Schreurs MWJ, Sillevis Smitt PAE, Titulaer MJ (2016) Anti-LGI1 encephalitis: clinical syndrome and long-term follow-up. Neurology 87:1449–1456. https://doi.org/10.1212/WNL.0000000000003173 CrossRefGoogle Scholar
- 30.Finke C, Prüss H, Heine J, Reuter S, Kopp UA, Wegner F, Then Bergh F, Koch S, Jansen O, Münte T, Deuschl G, Ruprecht K, Stöcker W, Wandinger KP, Paul F, Bartsch T (2017) Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies. JAMA Neurol 74:50–59. https://doi.org/10.1001/jamaneurol.2016.4226 CrossRefGoogle Scholar
- 31.van Sonderen A, Ariño H, Petit-Pedrol M, Leypoldt F, Körtvélyessy P, Wandinger KP, Lancaster E, Wirtz PW, Schreurs MWJ, Sillevis Smitt PAE, Graus F, Dalmau J, Titulaer MJ (2016) The clinical spectrum of Caspr2 antibody-associated disease. Neurology 87:521–528. https://doi.org/10.1212/WNL.0000000000002917 CrossRefGoogle Scholar
- 32.Hirai T, Korogi Y, Yoshizumi K, Shigematsu Y, Sugahara T, Takahashi M (2000) Limbic lobe of the human brain: evaluation with turbo fluid-attenuated inversion-recovery MR imaging. Radiology 215:470–475. https://doi.org/10.1148/radiology.215.2.r00ma06470 CrossRefGoogle Scholar